Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Liabilities and Shareholders Equity (2020 - 2025)

Universe Pharmaceuticals' Liabilities and Shareholders Equity history spans 6 years, with the latest figure at $69.3 billion for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 1.99% to $69.3 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $137.3 billion, a 101.64% increase, with the full-year FY2025 number at $69.3 billion, up 1.99% from a year prior.
  • Liabilities and Shareholders Equity hit $69.3 billion in Q3 2025 for Universe Pharmaceuticals, up from $68.0 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for UPC hit a ceiling of $69.3 billion in Q3 2025 and a floor of $41.7 million in Q3 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $17.2 billion across 5 years, with a median of $70.3 million in 2021.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 243521825.1% in 2021 and later fell 29.92% in 2023.
  • Tracing UPC's Liabilities and Shareholders Equity over 5 years: stood at $70.1 million in 2021, then fell by 15.12% to $59.5 million in 2022, then fell by 29.92% to $41.7 million in 2023, then skyrocketed by 162762.16% to $68.0 billion in 2024, then grew by 1.99% to $69.3 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for UPC at $69.3 billion in Q3 2025, $68.0 billion in Q3 2024, and $49.4 million in Q1 2024.